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Abstract: Aims: Non-invasive imaging of electrical activation requires high-density body surface poten-
tial mapping. The nine electrodes of the 12-lead electrocardiogram (ECG) are insufficient for a reliable
reconstruction with standard inverse methods. Patient-specific modelling may offer an alternative route
to physiologically constraint the reconstruction. The aim of the study was to assess the feasibility of
reconstructing the fully 3D electrical activation map of the ventricles from the 12-lead ECG and car-
diovascular magnetic resonance (CMR). Methods and results: Ventricular activation was estimated by
iteratively optimizing the parameters (conduction velocity and sites of earliest activation) of a patient-
specific model to fit the simulated to the recorded ECG. Chest and cardiac anatomy of 11 patients (QRS
duration 126-180 ms, documented scar in two) were segmented from CMR images. Scar presence was
assessed by magnetic resonance (MR) contrast enhancement. Activation sequences were modelled with
a physiologically based propagation model and ECGs with lead field theory. Validation was performed
by comparing reconstructed activation maps with those acquired by invasive electroanatomical mapping
of coronary sinus/veins (CS) and right ventricular (RV) and left ventricular (LV) endocardium. The
QRS complex was correctly reproduced by the model (Pearson’s correlation r = 0.923). Reconstructions
accurately located the earliest and latest activated LV regions (median barycentre distance 8.2 mm, IQR
8.8 mm). Correlation of simulated with recorded activation time was very good at LV endocardium (r =
0.83) and good at CS (r = 0.68) and RV endocardium (r = 0.58). Conclusion: Non-invasive assessment
of biventricular 3D activation using the 12-lead ECG and MR imaging is feasible. Potential applications
include patient-specific modelling and pre-/per-procedural evaluation of ventricular activation.
DOI: https://doi.org/10.1093/europace/euaa330






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Pezzuto, Simone; Prinzen, Frits W; Potse, Mark; Maffessanti, Francesco; Regoli, François; Caputo,
Maria Luce; Conte, Giulio; Krause, Rolf; Auricchio, Angelo (2021). Reconstruction of three-dimensional





biventricular activation based on the 12-lead
electrocardiogram via patient-specific
modelling
Simone Pezzuto 1*, Frits W. Prinzen2, Mark Potse 3,4,5, Francesco Maffessanti1,
François Regoli1,6, Maria Luce Caputo1,6, Giulio Conte1,6, Rolf Krause1, and
Angelo Auricchio1,6
1Center for Computational Medicine in Cardiology, Institute of Computational Science, Università della Svizzera italiana, Via Giuseppe Buffi 13, CH-6904 Lugano, Switzerland;
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Aims Non-invasive imaging of electrical activation requires high-density body surface potential mapping. The nine electro-
des of the 12-lead electrocardiogram (ECG) are insufficient for a reliable reconstruction with standard inverse
methods. Patient-specific modelling may offer an alternative route to physiologically constraint the reconstruction.
The aim of the study was to assess the feasibility of reconstructing the fully 3D electrical activation map of the ven-




Ventricular activation was estimated by iteratively optimizing the parameters (conduction velocity and sites of earli-
est activation) of a patient-specific model to fit the simulated to the recorded ECG. Chest and cardiac anatomy of
11 patients (QRS duration 126–180ms, documented scar in two) were segmented from CMR images. Scar pres-
ence was assessed by magnetic resonance (MR) contrast enhancement. Activation sequences were modelled with
a physiologically based propagation model and ECGs with lead field theory. Validation was performed by compar-
ing reconstructed activation maps with those acquired by invasive electroanatomical mapping of coronary sinus/
veins (CS) and right ventricular (RV) and left ventricular (LV) endocardium. The QRS complex was correctly
reproduced by the model (Pearson’s correlation r=0.923). Reconstructions accurately located the earliest and lat-
est activated LV regions (median barycentre distance 8.2mm, IQR 8.8mm). Correlation of simulated with recorded
activation time was very good at LV endocardium (r=0.83) and good at CS (r=0.68) and RV endocardium
(r=0.58).
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Conclusion Non-invasive assessment of biventricular 3D activation using the 12-lead ECG and MR imaging is feasible. Potential
applications include patient-specific modelling and pre-/per-procedural evaluation of ventricular activation.
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The standard 12-lead electrocardiogram (ECG) is the most routinely
used, inexpensive, and non-invasive modality to record the electrical
activity of the heart, but its diagnostic capability has acknowledged
limits. In particular, the surface ECG does not provide quantitative in-
formation about the activation sequence in the heart.
Non-invasive electrocardiographic imaging, also called ECG map-
ping, overcomes at least some of the limitations of the standard ECG.
ECG mapping combines information from many (usually 150–250)
electrodes with knowledge of the geometry of the heart and torso of
the patient to depict the electric activity of the heart.1 It is a general-
purpose tool that can reconstruct potentials, electrograms, and acti-
vation and repolarization patterns on either the epicardium or, less
commonly, the endocardium. Some technologies based on ECG
mapping have been extensively validated in experimental, animal, and
clinical studies, with convincing results.2–5 However, ECG mapping
relies on a large number of electrodes, placed on the patient’s torso
at the time of geometry acquisition using cardiac imaging as well as
during the clinical intervention, thus requiring dedicated technical
support and additional costs. Therefore, despite the advantages, its
adoption in the clinical workflow is still limited.
In this study, we assess the possibility to reconstruct the activation
map relying only on the 12-lead ECG for the electric data, by taking
advantage of physiological and anatomical knowledge implemented in
a patient-specific model. The parameters of the model, regional con-
duction velocities and sites of earliest activation, are automatically op-
timized to fit the simulated to the recorded QRS complex. The fitted
patient-specific model can calculate almost real-time the activation
sequence andmay therefore enable model-assisted therapeutic inter-
vention. Proof-of-principle validation was performed on a small, yet
heterogeneous cohort of patients possibly with a scar by an extensive
comparison of the calculated activation map against the invasively ac-
quired high-density electro-anatomic endocardial map.
Methods
Study population
Eleven heart failure patients were retrospectively included in the study; of
whom the following data were acquired: a 12-lead ECG, a clinically indi-
cated magnetic resonance (MR) scan with late gadolinium-enhancement
(LGE), and an electrophysiological study for measuring electro-
anatomical maps (EAMs). The institutional review board approved the
study protocol, and all patients gave written and oral informed consent
for the investigation. The study was performed in compliance with the
Declaration of Helsinki.
Construction of the patient-specific model
from cardiovascular magnetic resonance and
electrocardiogram
The overall workflow was based on a propagation model—the so-called
‘eikonal model’, previously described6—for simulating myocardial activa-
tion and the corresponding body surface 12-lead ECG. The model used a
volumetric anatomical description of the heart and torso. The electro-
physiological individualization of the model was achieved by identifying
the early activation sites (EASs) and regional conduction properties of
the myocardium by fitting the simulated QRS complex to the recorded
one (Figure 1). The corresponding activation was eventually extracted
from the propagation model using the identified parameters. Further
details on the mathematical and computational aspects are available in
Supplementary material online.
Anatomical model
The patient anatomies were semi-automatically reconstructed from the
cardiovascular magnetic resonance (CMR) images to create 1-mm reso-
lution 3D volumetric computational grids.7 Scarred tissue was inferred
from LGE-MRI sequences by manual contour drawing and alignment.
Ventricular fibre orientation was assigned using a rule-based approach.7
A 1 mm thick fast conducting layer was included in both left ventricular
(LV) and right ventricular (RV) endocardium. The torso model included
lungs, blood masses, active myocardium with fibre orientation, connec-
tive tissue, skeletal muscles, and skin.
Propagation model and electrocardiogram simulation
In the propagation model, the electrical activation originated from a lim-
ited number (1–10 per chamber) of endocardial EASs and spread across
the non-scarred myocardium with direction-dependent conduction ve-
locity. The parameters of the model included the EASs, the surface-to-
volume ratio of the cells, the intra- and extra-cellular conductivity, and a
scaling parameter accounting for the ionic membrane model. The propa-
gation was faster in the fibre direction than in the cross-fibre direction.
The QRS complex of the 12-lead ECG was simulated by using the lead
field theory.8 The transmembrane potential was a pre-computed tem-
plate function shifted in time according to activation.
Fitting procedure
The parameter fitting procedure consisted of two phases. The first phase
provided an initial estimate of the global CV and the number, location,
and onset of the EASs, whereas the second phase further optimized the
location of the EASs and the CV in four distinct regions (LV, RV and LV,
RV fast endocardial layer). Several other parameters (electric conductivi-
ties, membrane model) were left unchanged from those reported in pre-
vious studies. Initial guesses for the parameters were the same for all
patients.
Validation
Validation was performed by comparing the reconstructed activation
maps at LV and RV endocardium and in the coronary sinus (CS) and
veins with the EAMs as obtained from the electrophysiology study.
The mapping system was the NOGA-XP system (Biologic Delivery
Systems, Division of Biosense Webster, a Johnson&Johnson Company)
What’s new?
• Reconstruction of three-dimensional (3D) activation map with
only 12-lead electrocardiogram, patient-specific anatomy, and
cardiovascular magnetic resonance-derived scar using a propa-
gation model for the electric activation.
• Validation of reconstruction against endocardial and epicardial
(coronary sinus/veins) invasive, high-density electroanatomic
maps in 11 patients.
• Physiologically accurate conduction with heterogeneities (scar,
fast endocardial layer) and anisotropy (fibres).
• Enabling technology for non-invasive individualization of pa-
tient-specific models.



















































































































equipped with a conventional 7-Fr deflectable-tip mapping catheter
(NAVI-STAR, Biosense Webster). Unipolar electrograms and corre-
sponding spatial positions of the tip of the catheter were simulta-
neously acquired at 1 kHz and 100Hz, respectively, and aligned in
time using the automatically detected R-peak of the 12-lead ECG.
Points were accepted by the system according to a set of criteria for
catheter stability and signal quality.
Electro-anatomical maps and patient-specific anatomy were spatially
aligned by means of a translation and the acquired points were projected
onto the corresponding anatomical region (LV or RV endocardium, LV
epicardium). The LV earliest and latest activated regions (EAR and LAR)
were presented using a bull’s-eye plot. The EAR and LAR were respec-
tively defined as the earliest 10% and the latest 10% of activated endocar-
dium. The endocardial breakthrough point (BP) and latest activated point
(LAP) were defined as the centre of mass of the EAR and LAR, respec-
tively. A trans-septal time (TST) was defined as the earliest LV break-
through time, whereas the total activation time (TAT) was the maximal
difference in activation within the LV endocardium. The overlap (OVL)
between recorded and reconstructed activation was evaluated as area
of the overlap when 20% of the total endocardium was activated, divided
by 0.2.
Statistical analysis
Recorded and simulated ECGswere compared in terms of Pearson’s cor-
relation, relative root-mean-square error and QRS duration. A similar
analysis was applied to the pointwise comparison to EAMs. All distances
were computed using the Euclidean distance. Bland–Altman analyses
were carried out to evaluate the agreement between recorded and
reconstructed activation times. All quantities are reported in mean ± SD
ormedian and 1st and 3rd quartiles, if not indicated differently.
Results
The demographic characteristics of the cohort (Table 1) showed a
median age of 69 years and a prevalence of males (73%). Scar was
reported in three patients (27%). All patients had a long QRS dura-
tion (min 126ms, max 185ms). On average 265± 109 endocardial
activation points per patient were acquired. In 11 patients, 186± 59
LV endocardial points were collected, in 6 patients an additional
71± 22 points in the RV, and in 7 patients 63± 19 points were
recorded on the LV epicardium by introducing the mapping catheter
into the CS and whenever possible in the coronary veins. The EAMs
confirmed aleft bundle branch block condition in nine patients (82%).
The median TST and TAT were, respectively, 54ms (IQR 44–68ms)
and 76ms (IQR 73–81ms), and only two patients showed short TST
(Table 1).
Detection of early activation sites
An illustrative example of the fitted patient-specific models is repro-
duced in Figure 2 for an IVCD patient with coronary artery disease
(Patient #4). The patient has a non-LBBB QRS morphology and an
extensive sub-endocardial scar located in the LV antero-lateral wall.
The algorithm identified 14 EASs, 7 RV and 7 LV. No RV-LV delay
was observed. In the LV, BPs were in the septal area both inferiorly
and anteriorly, with a slightly higher occurrence in the inferior sec-
tors. The simulated and recorded QRS complexes correlated excel-
lently (r=0.978). The BP and LAP localization errors were 11.1 and
8.9 mm, respectively. Notably, four EARs were correctly identified,
with two EARs in the antero-septal area and two EARs in the
inferior-septal area, very close to the recorded EAR in the same area.
Figure 1 Summary of the method. The workflow starts with the CMR acquisition of the anatomy of the heart and the torso (with electrode posi-
tions) and the standard 12-lead ECG (blue box). In the pre-processing phase (yellow box), a 3D anatomy of the patient is reconstructed from CMR/
CT sequences. The parameter identification phase (light green box) aims at fitting the parameters of themodel (CVs and EASs) to minimize the differ-
ence between recorded and simulated ECG. The reconstructed activation map was eventually validated against invasive EAM (dashed light blue box).
CMR, cardiovascular magnetic resonance; CT, computed tomography; CV, conduction velocity; EASs, early activation sites; ECG, electrocardiogram.



















































































































Pointwise correlation between calculated and measured points was
0.78 and OVL 0.4.
Overall accuracy of reconstructed
activation
A pointwise comparison of reconstructed activation at points from
EAM (Table 2) showed very high Pearson’s correlation (r=0.815),
particularly at LV endocardium (r=0.833). In the RV endocardium
and CS/veins the correlation was lower (r=0.576 and 0.677). The
Bland–Altman analysis showed no bias (0.45ms) and limits of agree-
ment (LoA) of42.7 andþ43.6ms (2856 points). On the LV epicar-
dium and endocardium, the reconstruction was good (r>0.7) in 10
patients (91%) and modest only in Patient #3 (r=0.33). On the RV
endocardium Pearson correlation per patient was generally modest
(r>0.5 in four patients of the six) and poor in Patient #6 (r=0.18). A
....................................................................................................................................................................................................................
Table 1 Characteristics of the patients
Patient ID Sex Age (years) Scar ECG QRSd (ms) TST (ms) TAT (ms)
1 F 72 No LBBB, SR 139 39 81
2 M 69 No LBBB, AF 179 59 91
3 M 79 Yes (8) IVCD, SR 138 3 81
4 M 57 Yes (6) IVCD, SR 126 14 72
5 F 68 No LBBB, SR 185 69 75
6 M 53 No LBBB, SR 165 50 76
7 F 67 No LBBB, SR, AVB1 156 72 48
8 M 68 No LBBB, SR 154 54 63
9 M 73 Yes (1) LBBB, SR, AVB1 176 77 77
10 M 84 No LBBB, SR, AVB1 180 50 98
11 M 69 No LBBB, SR, AVB1 170 68 74
Overall 73% M 69±8.7 27% Yes 82% LBBB 160.7± 18.81 50.45± 22.6 76± 12.6
Statistics are reported in the last row as average ± standard deviation for numerical data and as percentage for categorical data.
AVB1, atrioventricular block first degree; ECG, electrocardiogram; F, female; IVCD, intraventricular conduction delay; LBBB, left bundle branch block; M, male; QRSd, QRS
complex duration; SR, sinus rhythm; TST, trans-septal time; TAT, total activation time.
A B
C D
Figure 2 Illustrative reconstruction. Example of the activation reconstruction for Patient #4. (A) Recorded (blue) and fitted (orange) ECG. (B) 3D
cut view of the activation map with collected EAM points, and epicardial views. (C) LV bull’s-eye plot. (D) LV endocardial view of interpolated EAM
(scar in purple). EAM, electro-anatomical maps; ECG, electrocardiogram; LV, left ventricular.



















































































































relatively large bias of 27ms was observed on the RV endocardium
with LoA18 and 72ms.
The estimated TST obtained from the fitted model closely
matched the measured TST (difference between reconstructed and
recorded was 15.5± 16.5ms) in all but one. The reconstructed
TAT slightly overestimated the recorded one, with a difference of
25.7± 22ms.
The BP and LAP in the LV were accurately identified in the correct
AHA sector on the bull’s-eye plot in the majority of the patients
(72%). In the remaining cases, BP was placed in the neighbouring seg-
ments (Figure 3). The distance between the calculated and the
recorded BP was 13.5 (6.9–16.1) mm, and the OVL was 0.75 (0.56–
0.79). The LAP was also accurately captured by the reconstructed ac-
tivation map, 8.1 (6.1–14.5) mm off the recorded position.
Accuracy of fitting the
electrocardiogram
Overall, the fitted QRS complex was highly correlated to the
recorded QRS complex (r=0.92) and correlation was >0.9 in 9 of
the 11 patients (82%). Per-patient correlation (Table 3) ranged from
0.84 (Patient #7) to 0.98 (Patient #6). The QRS duration was well
captured, reporting an error (reconstructed minus recorded) of
3.0 [17.37–5.28] ms. Overall, V1-V4 showed very high correla-
tion while lead V6 and aVR showed modest correlation.
Discussion
This study shows that a mathematical model can accurately recon-
struct the volumetric propagation sequence of the ventricles in heart
failure patients during sinus rhythm. In contrast to commercially avail-
able ECG mapping technologies, it does not require hundreds of
electrodes; we obtained our results with only the 12-lead ECG and
standard imaging data. Themethod can be easily integrated in existing
EAM systems, possibly reducing mapping time, and increasing locali-
zation accuracy.
Our method is neither the first to require only a 12-lead ECG9,10
nor the first to predict the activation sequence in the entire ventricu-
lar volume,11 but it is the first to achieve both of these feats without
compromising the physiological accuracy or strongly limiting the ap-
plicability of the approach. Our method combines the best of two
worlds: ECG mapping1,2,11–13 and patient-specific modelling.14–16
Due to a highly optimized implementation the reconstruction is com-
petitive in terms of time to solution to other ECG mapping
approaches. At the same time, the accuracy of its ECG prediction is
comparable with the gold standard, the bidomain model.6 We
achieve this accuracy by using a volumetric conduction model, neces-
sary to incorporate the effect of tissue anisotropy on the potential
field generated by the activation wavefront. This automatically results
in a fully 3D prediction of the activation sequence. The activation se-
quence itself was simulated realistically with an anisotropic eikonal
equation.
Accuracy
The overall correlation of the activation map in the present study
(r=0.82) is comparable with those reported for ECG epicardial map-
ping in closed-chest pig experiments (r=0.82 and 0.78)3,4 and in clini-
cal studies during pacing (r=0.62± 0.16).5 Studies performed during
sinus rhythm, better reflecting our cohort, showed significantly lower
correlation (r=0).17 Importantly, we did not observe potentially
unphysiological lines of block and U-shaped activation, often present
in ECG mapping, because conduction velocity cannot change
abruptly unless directly specified in the model.
The reconstruction of the activation was also accurate at the LV
endocardium, which is inaccessible for potential-based ECG mapping
approaches. Several ECG mapping methods for endocardial activa-
tion are available,2,12,13 but validation data during sinus rhythm
are scarce. Our localization error of BP and LAP in the LV
(12.2± 8.8mm) is comparable with those during atrioventricular
conduction in patients with ventricular pre-excitation (18.7 ±
6.4mm)2 but higher than those during single pacing (6.5± 2.1 and
6± 5mm).12,13 For those methods only relying on the 12-lead ECG,
localization error during pacing was significantly higher (>20mm) but
predicted the correct segment.9,16 Our method also recorded a
good similarity (in terms of overlap) between recorded and recon-
structed earliest activation (0.69± 0.17) as a metric for accuracy in
the reconstruction. While a small localization error suggests an accu-
rate reconstruction of BP and LAP location, a large overlap indicates
that conduction properties are also correct.
The reconstruction of the CS/veins map adequately reproduced
the invasive recordings. In contrast, the RV activation reconstruction
was modest in terms of correlation (r=0.58) and showed on average
a deviation from the EAM of 27ms. A closer inspection of the Bland-
Altman plot suggests that points in the earliest activated region were
well reproduced while late-activated points were considerably
delayed in the reconstructed map. The RV contributes less than the
LV to the ECG, and the least-squares minimization used here tends
to ignore small deviations in amplitude, hence limiting the accuracy.
Additionally, the alignment of the recorded RV points to the anatomy
.................................................................................................
Table 2 Correlation between EAMs and recon-
structed activation times for all points in the LV and
RVendocardium and LVepicardium in all patients
Patient ID LVendo LVepi RVendo Overall
1 0.953 — — 0.953
2 0.903 — — 0.903
3 0.327 — — 0.327
4 0.777 — — 0.777
5 0.885 0.966 0.735 0.805
6 0.765 0.863 0.188 0.797
7 0.751 0.863 0.496 0.788
8 0.893 0.952 0.509 0.878
9 0.942 0.932 0.323 0.817
10 0.914 0.949 0.759 0.840
11 0.720 0.782 — 0.831
Overall 0.833 0.677 0.576 0.816
EAMs, electroanatomic maps; endo, endocardial; epi, epicardial; LV, left ventricu-
lar; RV, right ventricular.
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Figure 3 Validation against invasive mapping. Bull’s-eye plots for each patient showing the EAR (blue) and LAR (red) in the LV. The solid-coloured
regions refer to the recorded maps, while the hatched-coloured regions are the reconstructed ones. Scar is in purple. BPs are marked by stars. BP,
breakthrough point; EAR, earliest activated region; LAR, latest activated region; LV, left ventricular.
....................................................................................................................................................................................................................
Table 3 Correlation between recorded and fitted ECG, grouped by patient and lead
ID I II III V1 V2 V3 V4 V5 V6 aVF aVL aVR All
1 0.941 0.886 0.918 0.979 0.947 0.972 0.863 0.375 0.889 0.852 0.935 0.939 0.934
2 0.191 0.920 0.928 0.849 0.885 0.991 0.949 0.754 0.364 0.934 0.905 0.572 0.881
3 0.966 0.861 0.979 0.951 0.934 0.983 0.986 0.978 0.301 0.958 0.984 0.432 0.944
4 0.707 0.969 0.961 0.975 0.995 0.993 0.989 0.882 0.973 0.971 0.916 0.940 0.978
5 0.899 0.623 0.879 0.968 0.996 0.986 0.981 0.469 0.646 0.799 0.919 0.630 0.963
6 0.979 0.959 0.938 0.978 0.990 0.984 0.914 0.853 0.907 0.847 0.971 0.978 0.981
7 0.800 0.591 0.935 0.964 0.991 0.940 0.930 0.759 0.246 0.852 0.942 0.341 0.843
8 0.908 0.732 0.914 0.979 0.961 0.988 0.985 0.981 0.941 0.869 0.937 0.002 0.935
9 0.872 0.819 0.687 0.967 0.937 0.982 0.975 0.817 0.306 0.518 0.081 0.864 0.917
10 0.870 0.858 0.418 0.941 0.953 0.946 0.622 0.767 0.905 0.622 0.819 0.878 0.932
11 0.918 0.930 0.666 0.981 0.978 0.956 0.877 0.198 0.840 0.892 0.846 0.931 0.940
All 0.855 0.845 0.833 0.923 0.956 0.940 0.936 0.687 0.555 0.830 0.852 0.842 0.923
ECG, electrocardiogram.



















































































































is problematic and may be affected by large uncertainty, because of
the concave shape of the chamber.
Patient-specific modelling
By virtue of its model-based nature, our approach has the potential
to further improve the individualization in patient-specific modelling,
an emerging paradigm aiming at supporting personalized therapeutic
interventions.18 Personalization of cardiac models from 12-lead ECG
has already been investigated by others.10,14–16Compared with those
methods our approach is more general, being capable of identifying
an optimal set of EAMs with no restriction on the number of sites,
and very competitive in terms of time to solution, hence widening
the spectrum of clinical applications.
Robustness of validation
The activation map extrapolated from the invasive mapping system
may be affected by several uncertainties. The detection of the activa-
tion time from EGM could be difficult because of fractionation and far
field signal in the unipolar readings and direction-dependency in bipo-
lar signals.19 In addition, the spatial location of imaged points needs to
be registered to the electrode positions. The combination of both
these uncertainties (in space and in time) may affect the comparison,
especially for BP and LAP localization. In this work, we opted for the
more robust definition of BP (respectively LAP) as the centre of mass
of the EAR (respectively LAR). In a Monte Carlo study, we found that
the localization error of BP has significantly lower variance if defined
as above instead of as the earliest activated point (see Supplementary
material online).
Perspectives on clinical application
Our method could be included in the screening workflow of patients
who are candidate to CRT as well as in selecting pacing targets. The
measurement of the time interval between RV and LV, or the time
between Q wave on surface ECG and LV at the time of CRT implan-
tation has been predictive of both acute and chronic response to
CRT.20 The method could easily estimate both RV-LV timing and Q-
LV time and thus provide a novel way for patient selection and pre-
procedural planning of RV and LV lead placement. Patient-specific ac-
tivation patterns can be calculated right at the time of pacing lead
placement.
Study limitations
The patient-specific model has several parameters with considerable
uncertainty. This is an undeniable problem of current cardiac models
and, more generally, biological systems. Given the limited amount of
data we use for the fitting and the complexity of the model, we had
to minimize the number of free parameters. It is still possible how-
ever, that multiple combinations of parameters yield similar activation
maps and surface ECG. The solution may therefore depend on the
initial guess for the parameters and the optimization algorithm. To al-
leviate this problem, we designed the first phase of the algorithm to
provide a robust initial guess.
The eikonal model does not cover the full spectrum of activation
patterns. This may limit its applicability. Most notably, re-entrant acti-
vation is not admissible in our current formulation.
The study was admittedly based on a small patient cohort.
However, this cohort was heterogeneous, with QRS duration rang-
ing from 126 to 180ms, different ventricular conduction abnormali-
ties and variable underlying disease (e.g. scar). Importantly, the
validation measurements consisted of high-resolution endocardial
mapping in both ventricles and epicardial LV measurements (limited
to CS/veins) in heart failure patients during sinus rhythm.
The validation analysis in this study was not performed blindly to
the intracardial mapping. To avoid a possible bias, we used the same
initial guess in the algorithm for all the patients, despite the heteroge-
neity of the cohort.
Currently, the model requires an accurate segmentation and
mesh-construction from imaging data, which may require several
hours per patient. For the majority of applications, a preparatory
phase of several hours is reasonable and it does not disrupt the clini-
cal workflow. Nonetheless, time to segmentation can nowadays be
improved significantly by a combination of statistical atlases and ma-
chine learning.
Finally, scar was assessed by LGE-MRI acquisitions, which might
not be routinely available. We also did not consider the border zone
of the scar in the model, although the model can easily allow for it.
Conclusions
A 12-lead ECG-based technique for reconstructing cardiac activation
was developed and validated. The methodology achieved very good
endocardial accuracy, opening the possibility for a non-invasive pre-
and peri-procedural evaluation of activationmap during intrinsic sinus
rhythm and, potentially, for guiding optimal lead placement.
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